Publications of B. Kalbfuss

Kalbfuss, B., Flockerzi, D., Seidel-Morgenstern, A., & Reichl, U. (2008)Size-exclusion chromatography as a linear transfer system: Purification of human influenza virus as an exampleJournal of Chromatography B, 873 (1), 102–112doi: 10.1016/j.jchromb.2008.08.002.

Kalbfuss, B., Knöchlein, A., Kröber, T., & Reichl, U. (2008)Monitoring Influenza Virus Content in Vaccine Production: Precise Assays for the Quantitation of Hemagglutination and Neuraminidase ActivityBiologicals, 36 (3), 145–161doi: 10.1016/j.biologicals.2007.10.002.

Kalbfuss, B., Genzel, Y., Wolff, M. W., Zimmermann, A., Morenweiser, R., & Reichl, U. (2007)Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccinesBiotechnology and Bioengineering, 97 (1), 73–85doi: 10.1002/bit.21139.

Kalbfuss, B., Wolff, M. W., Geisler, L., Tappe, A., Wickramasinghe, R., Thom, V., & Reichl, U. (2007)Direct capture of influenza A virus from cell culture supernatant with Sartobind anion-exchange membrane adsorbersJournal of Membrane Science, 299, 251–260doi: 10.1016/j.memsci.2007.04.048.

Kalbfuss, B., Wolff, M. W., Morenweiser, R., & Reichl, U. (2007)Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatographyBiotechnology and Bioengineering, 96, 932–944doi: 10.1002/bit.21109.

Kalbfuss, B. & Reichl, U. (2006)Preparative Size-Exclusion ChromatographyGIT Laboratory Journal Europe, 10 (4), 18–20.

Wickramasinghe, S. R., Kalbfuss, B., Zimmermann, A., Thom, V., & Reichl, U. (2005)Tangential flow microfiltration and ultrafiltration for human influenza A virus concentration and purificationBiotechnology and Bioengineering, 92 (2), 199–208doi: 10.1002/bit.20599.

Genzel, Y., Kalbfuss, B., Ritter, J. B., Schulze-Horsel, J., Rapp, E., Vester, D., & Reichl, U.Characterization and analytical issues on an influenza A virus production processPresented at: Vaccines : Quality control, scale-up and manufactureHamburg, Germany, December 5, 2006.

Kalbfuss, B., Gedicke, K., Seidel-Morgenstern, A., & Reichl, U.Maximizing productivity in size-exclusion chromatography of influenza virus: A modelling approachPresented at: ESBES 6 : 6th European Symposium on Biochemical Engineering ScienceSalzburg, Austria, August 27, 2006.

Kalbfuss, B., Wolff, M. W., Geisler, L., Thom, V., & Reichl, U.Konzentrierung und Aufreinigung von Influenza Viren mittels Ionenaustauscher-MembranenPresented at: 24. DECHEMA-Jahrestagung der BiotechnologenWiesbaden, Germany, September 26, 2006.

Kalbfuss, B., Wolff, M. W., Genzel, Y., Zimmermann, A., Best, C., Morenweiser, R., & Reichl, U.A generic purification scheme for the production of human influenza vaccines derived from serum-free mammalian cell culturePresented at: Vaccine TechnologyPuerto Vallarta, Mexico, June 25, 2006.

Kalbfuss, B., Wolff, M. W., Genzel, Y., Zimmermann, A., Morenweiser, R., & Reichl, U.Chromatography-based purification of influenza A virus for the production of human whole-virion vaccinesPresented at: ISPPP 2006 : 26th International Symposium on the Separation of Proteins, Peptides and PolynucleotidesInnsbruck, Austria, October 17, 2006.

Wolff, M. W., Kalbfuss, B., Lehmann, S., Morenweiser, R., Opitz, L., Zimmermann, A., & Reichl, U.Downstream Processes and Glycan Characterization of MDCK-Cell Derived Influenza VirusPresented at: BioProcess Technology - AsiaSingapore, June 26, 2006.

Wolff, M. W., Kalbfuss, B., Opitz, L., Zimmermann, A., Lehmann, S., & Reichl, U.Downstream Process of Influenza VirusesPresented at: European BioPharm Scale-Up Congress 2006Geneva, Switzerland, September 12, 2006.

Wolff, M., Kalbfuss, B., Morenweiser, R., Zimmermann, A., & Reichl, U.Chromatography-based Purification of Influenza A Virus for the Production of Human Whole-Virion VaccinesPresented at: Viral Vectors and Vaccines ConferenceAustin, Texas, November 14, 2005.

Wolff, M. W., Salaklang, J., Opitz, L., Schwarzer, J., Rapp, E., Kalbfuss, B., & Reichl, U.Development of a lectin-affinity chromatography step for the downstream processing of influenza virus vaccinesPresented at: AICHE Annual Meeting 2005Cincinnati, Ohio, USA, October 30, 2005.

Opitz, L., Wolff, M. W., Salaklang, J., Rapp, E., Kalbfuss, B., & Reichl, U.Lectin-affinity purification of cell culture derived human Influenza A virusesPresented at: Vaccine Technology 2006Puerto Vallarta, Mexico, June 25, 2006.

Kalbfuss, B., Zimmermann, A., Genzel, Y., & Reichl, U.Generic Process Scheme for Particle-Based Purification of Cell Culture Derived Influenza A VirusPresented at: BioperspectivesWiesbaden, Germany, May 10, 2005.

Kalbfuss, B., Zimmermann, A., Wickramasinghe, B., Morenweiser, R., & Reichl, U.Tangential Flow Filtration of Influenza Virus as a Model SystemPresented at: Engineering with MembranesCamogli, Italy, May 22, 2005.

Kalbfuß, B. (2009)Downstream Processing of Influenza Whole-Virions for Vaccine ProductionPhD Thesis, Otto-von-Guericke-Universität, Magdeburgdoi: 10.25673/5014.